Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists

被引:24
|
作者
Xia, Lizi [1 ]
Burger, Wessel A. C. [1 ]
van Veldhoven, Jacobus P. D. [1 ]
Kuiper, Boaz J. [1 ]
van Duijl, Tirsa T. [1 ]
Lenselink, Eelke B. [1 ]
Paasman, Ellen [1 ]
Heitman, Laura H. [1 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands
关键词
PROTEIN-COUPLED RECEPTOR; TARGET RESIDENCE TIME; MEDICINAL CHEMISTRY; CLICK CHEMISTRY; LIGAND; BINDING; RADIOLIGAND; THERMODYNAMICS; GPCRDB;
D O I
10.1021/acs.jmedchem.7b00950
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery.
引用
收藏
页码:7555 / 7568
页数:14
相关论文
共 47 条
  • [41] Quantitative structure-activity relationship study of human A3 adenosine receptor antagonists:: Derivatives of 2-aryl-1,2,4-triazolo [4,3-α]quinoxaline
    Sharma, B. K.
    Singh, P.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (02) : 165 - 169
  • [42] Structure activity relationships at the human A2B adenosine receptor of xanthine derivatives substituted at 1-, 3-, 7- and 8-positions.
    Kim, SA
    Marshall, MA
    Melman, N
    Muller, CE
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U64 - U64
  • [43] Structure-activity relationships of 2-chloro-N6-substituted-4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A3 adenosine receptor
    Jeong, LS
    Lee, HW
    Jacobson, KA
    Kim, HO
    Shin, DH
    Lee, JA
    Gao, ZG
    Lu, CR
    Duong, HT
    Gunaga, P
    Lee, SK
    Jin, DZ
    Chun, MW
    Moon, HR
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 273 - 281
  • [44] Corticotropin releasing factor-1 receptor antagonists: Synthesis and structure-activity relationships of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives.
    Hartz, RA
    Nanda, KK
    Ingalls, CL
    Ahuja, VT
    Molski, TF
    Mattson, GK
    Zhang, G
    Wong, H
    Zaczek, R
    Trainor, GL
    Gilligan, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U62 - U62
  • [45] Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists
    Inami, Hiroshi
    Shishikura, Jun-ichi
    Yasunaga, Tomoyuki
    Ohno, Kazushige
    Yamashita, Hiroshi
    Kato, Kota
    Sakamoto, Shuichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (08) : 1788 - 1799
  • [46] Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as RAF-MEK-ERK pathway signaling pathway blockers: Synthesis, cytotoxic activity, mechanistic investigation and structure-activity relationships
    Xie, Qian
    Shen, Yanni
    Meng, Yanli
    Liang, Jianhui
    Xu, Jing
    Liang, Shishao
    Liu, Xiaoping
    Wang, Yan
    Hu, Chun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [47] Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3′,2′:3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2′,3′: 4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5′-monophosphate-activated protein kinase (AMPK)
    Gu, Zhanni
    Wu, Lingyan
    Duan, Yanan
    Wang, Jiang
    Zhou, Shengbin
    Li, Jingya
    Chen, Kaixian
    Li, Jia
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 2017 - 2027